Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma

Cyclin Y (CCNY) is a novel cyclin and almost nothing is known about its role in human cancers. To investigate the clinical significance of serum anti-CCNY autoantibodies in nonsmall-cell lung carcinoma (NSCLC), the serum levels of CCNY protein in 264 patients with NSCLC, 103 patients with tuberculos...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Li, Yue, Wentao, Teng, Yu, Zhang, Lina, Gu, Meng, Wang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789285/
https://www.ncbi.nlm.nih.gov/pubmed/24167380
http://dx.doi.org/10.1155/2013/935943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789285/
https://www.ncbi.nlm.nih.gov/pubmed/24167380
http://dx.doi.org/10.1155/2013/935943

Ejemplares similares